Search research articles
Contact Us
Filters
Showing results (41-50 of 52) with videos related to
Page
of 6
Sort By:
Journal of the National Cancer Institute
|
February 3, 1993
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer
D C Allred, G M Clark, R Elledge, et al.
Breast Cancer Research and Treatment
|
June 28, 2005
Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer
G Arpino, D R Ciocca, H Weiss, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 14, 2021
In Reply to Nieder
Sara R Alcorn, Jacob Fiksel, Jean L Wright, et al.
Diagnostic Pathology
|
February 11, 2019
Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics
Carlos G Romo, Doreen N Palsgrove, Ananyaa Sivakumar, et al.
Cancer
|
November 10, 2020
A multi-institutional phase 2 trial of stereotactic body radiotherapy in the treatment of bone metastases in pediatric and young adult patients with sarcoma
Christen R Elledge, Matthew J Krasin, Matthew M Ladra, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 25, 2020
Developing an Improved Statistical Approach for Survival Estimation in Bone Metastases Management: The Bone Metastases Ensemble Trees for Survival (BMETS) Model
Sara R Alcorn, Jacob Fiksel, Jean L Wright, et al.
Gynecologic Oncology
|
June 22, 2020
Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations
Christen R Elledge, Sushil Beriwal, Cyrus Chargari, et al.
Journal of Evaluation in Clinical Practice
|
January 28, 2022
Improving providers' survival estimates and selection of prognosis- and guidelines-appropriate treatment for patients with symptomatic bone metastases: Development of the Bone Metastases Ensemble Trees for Survival Decision Support Platform
Sara R Alcorn, Christen R Elledge, Anna W LaVigne, et al.
JCO Clinical Cancer Informatics
|
March 24, 2021
External Validation of the Bone Metastases Ensemble Trees for Survival (BMETS) Machine Learning Model to Predict Survival in Patients With Symptomatic Bone Metastases
Christen R Elledge, Anna W LaVigne, Jacob Fiksel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2001
A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patients
M A Villalona-Calero, J L Blum, S E Jones, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 52) with videos related to
Sort By:
Page
of 6
Journal of the National Cancer Institute
|
February 3, 1993
Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer
D C Allred, G M Clark, R Elledge, et al.
Breast Cancer Research and Treatment
|
June 28, 2005
Predictive value of apoptosis, proliferation, HER-2, and topoisomerase IIalpha for anthracycline chemotherapy in locally advanced breast cancer
G Arpino, D R Ciocca, H Weiss, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 14, 2021
In Reply to Nieder
Sara R Alcorn, Jacob Fiksel, Jean L Wright, et al.
Diagnostic Pathology
|
February 11, 2019
Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics
Carlos G Romo, Doreen N Palsgrove, Ananyaa Sivakumar, et al.
Cancer
|
November 10, 2020
A multi-institutional phase 2 trial of stereotactic body radiotherapy in the treatment of bone metastases in pediatric and young adult patients with sarcoma
Christen R Elledge, Matthew J Krasin, Matthew M Ladra, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 25, 2020
Developing an Improved Statistical Approach for Survival Estimation in Bone Metastases Management: The Bone Metastases Ensemble Trees for Survival (BMETS) Model
Sara R Alcorn, Jacob Fiksel, Jean L Wright, et al.
Gynecologic Oncology
|
June 22, 2020
Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations
Christen R Elledge, Sushil Beriwal, Cyrus Chargari, et al.
Journal of Evaluation in Clinical Practice
|
January 28, 2022
Improving providers' survival estimates and selection of prognosis- and guidelines-appropriate treatment for patients with symptomatic bone metastases: Development of the Bone Metastases Ensemble Trees for Survival Decision Support Platform
Sara R Alcorn, Christen R Elledge, Anna W LaVigne, et al.
JCO Clinical Cancer Informatics
|
March 24, 2021
External Validation of the Bone Metastases Ensemble Trees for Survival (BMETS) Machine Learning Model to Predict Survival in Patients With Symptomatic Bone Metastases
Christen R Elledge, Anna W LaVigne, Jacob Fiksel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2001
A phase I and pharmacologic study of capecitabine and paclitaxel in breast cancer patients
M A Villalona-Calero, J L Blum, S E Jones, et al.
Page
of 6